SOLARA ACTIVE PHARMA [SOLARAPP1] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

SOLARA ACTIVE PHARMA SCIENCES

BSE
Loading...

Aarti Drugs Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: SOLARA ACTIVE PHARMA SCIENCES wins in 5 metrics, Aarti Drugs Ltd. wins in 14 metrics, with 0 ties. Aarti Drugs Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric SOLARA ACTIVE PHARMA SCIENCES Aarti Drugs Ltd. Better
P/E Ratio (TTM) 300.92 16.37 Aarti Drugs Ltd.
Price-to-Book Ratio 1.05 2.43 SOLARA ACTIVE PHARMA SCIENCES
Debt-to-Equity Ratio 51.38 39.05 Aarti Drugs Ltd.
PEG Ratio -1.02 1.75 Aarti Drugs Ltd.
EV/EBITDA 11.85 12.87 SOLARA ACTIVE PHARMA SCIENCES
Profit Margin (TTM) -1.52% 8.03% Aarti Drugs Ltd.
Operating Margin (TTM) 3.37% 6.16% Aarti Drugs Ltd.
EBITDA Margin (TTM) 3.37% 6.16% Aarti Drugs Ltd.
Return on Equity 0.05% 12.28% Aarti Drugs Ltd.
Return on Assets (TTM) 0.02% 6.53% Aarti Drugs Ltd.
Free Cash Flow (TTM) $1.73B $674.22M SOLARA ACTIVE PHARMA SCIENCES
Dividend Yield N/A 0.53% N/A
1-Year Return 13.08% -14.30% SOLARA ACTIVE PHARMA SCIENCES
Price-to-Sales Ratio (TTM) 1.66 1.31 Aarti Drugs Ltd.
Enterprise Value $19.97B $38.50B Aarti Drugs Ltd.
EV/Revenue Ratio 1.59 1.53 Aarti Drugs Ltd.
Gross Profit Margin (TTM) 46.53% 35.74% SOLARA ACTIVE PHARMA SCIENCES
Revenue per Share (TTM) $231 $276 Aarti Drugs Ltd.
Earnings per Share (Diluted) $-4.82 $22.09 Aarti Drugs Ltd.
Beta (Stock Volatility) 0.84 0.24 Aarti Drugs Ltd.

SOLARA ACTIVE PHARMA SCIENCES vs Aarti Drugs Ltd. Stock Performance Analysis

Loading Price Chart...

SOLARAPP1
AARTIDRUGS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
SOLARA ACTIVE PHARMA SCIENCES12.87%2.56%2.47%-20.88%-31.50%-20.88%
Aarti Drugs Ltd.-0.94%-3.20%-4.41%4.98%-7.86%-9.18%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
SOLARA ACTIVE PHARMA SCIENCES13.08%31.31%31.31%31.31%31.31%31.31%
Aarti Drugs Ltd.-14.30%-16.64%-49.93%230.78%2,195.72%3,618.48%

Performance & Financial Health Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Aarti Drugs Ltd.

MetricSOLARAPP1AARTIDRUGS
Market Information
Market Cap i₹20.78B₹33.96B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i238141,078
90 Day Avg. Volume i704139,729
Last Close₹308.70₹374.85
52 Week Range₹247.95 - ₹511.00₹318.95 - ₹564.05
% from 52W High-39.59%-33.54%
All-Time High₹511.00 (Aug 29, 2025)₹1,026.95 (Oct 05, 2020)
% from All-Time High-39.59%-63.50%
Growth Metrics
Quarterly Revenue Growth0.16%0.08%
Quarterly Earnings Growth0.16%0.09%
Financial Health
Profit Margin (TTM) i-0.02%0.08%
Operating Margin (TTM) i0.03%0.06%
Return on Equity (TTM) i0.00%0.12%
Debt to Equity (MRQ) i51.3839.05
Cash & Liquidity
Book Value per Share (MRQ)₹293.20₹148.52
Cash per Share (MRQ)₹0.88₹2.69
Operating Cash Flow (TTM) i₹1.70B₹2.83B
Levered Free Cash Flow (TTM) i₹5.40M₹1.68B
Dividends
Last 12-Month Dividend Yield iN/A0.53%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Aarti Drugs Ltd.

MetricSOLARAPP1 (Apr 08, 2026)AARTIDRUGS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i300.9216.37
Forward P/E iN/A14.64
PEG Ratio i-1.021.75
Price to Sales (TTM) i1.661.31
Price to Book (MRQ) i1.052.43
Market Capitalization
Market Capitalization i₹20.78B₹33.96B
Enterprise Value i₹19.97B₹38.50B
Enterprise Value Metrics
Enterprise to Revenue i1.591.53
Enterprise to EBITDA i11.8512.87
Risk & Other Metrics
Beta i0.840.24
Book Value per Share (MRQ) i₹293.20₹148.52

Financial Statements Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Aarti Drugs Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSOLARAPP1 (2025)AARTIDRUGS (2025)
Revenue/Sales i12.41B23.69B
Cost of Goods Sold i6.46B18.90B
COGS % of Revenue i52.0%79.8%
Gross Profit i5.96B4.79B
Gross Margin i48.0%20.2%
Research & Development iN/AN/A
Operating Income (EBIT) i1.11B2.43B
Operating Margin i9.0%10.3%
EBITDA i2.05B3.07B
EBITDA Margin i16.5%13.0%
Pre-Tax Income i5.40M2.12B
Pre-Tax Income % of Revenue i0.0%8.9%
Income Tax i0436.74M
Income Tax % of Revenue i0.0%1.8%
Net Income (Profit) i5.40M1.68B
Profit Margin i0.0%7.1%

Balance Sheet & Liquidity Metrics

MetricSOLARAPP1 (2025)AARTIDRUGS (2025)
Cash & Equivalents i39.50M45.77M
Total Current Assets i7.29B13.38B
Total Current Assets % of Revenue i58.7%56.5%
Total Current Liabilities i9.44B8.37B
Total Current Liabilities % of Revenue i76.0%35.3%
Long-Term Debt i1.32B2.86B
Long-Term Debt % of Revenue i10.6%12.1%
Total Shareholders Equity i10.97B13.69B
Retained Earnings i-3.16B12.40B
Retained Earnings % of Revenue i-25.4%52.4%
Property, Plant & Equipment i7.96B27.03M

Cash Flow Statement Comparison

MetricSOLARAPP1 (2025)AARTIDRUGS (2025)
Operating Cash Flow i1.70B2.83B
Operating Cash Flow % of Revenue i13.7%11.9%
Capital Expenditures i3.80M480,000
Free Cash Flow i1.73B674.22M
FCF Margin i13.9%2.8%
Debt Repayment i-1.11B-776.08M
Common Stock Repurchase iN/A-598.50M

Short Interest & Institutional Ownership Analysis

MetricSOLARAPP1AARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.00M91.27M
Float Shares i30.10M35.37M
% Held by Insiders i0.00%59.48%
% Held by Institutions i4.45%11.04%
% Held by Public i95.55%29.48%

Dividend Analysis & Yield Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Aarti Drugs Ltd.

MetricSOLARAPP1AARTIDRUGS
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.53%
3-Year Avg Annual Dividend iN/A₹1.33
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A₹4.00
Ex-Dividend DateN/AFeb 09, 2026